RecruitingNCT03954574

Pulmonary Hemodynamics During Exercise - Research Network


Sponsor

Medical University of Graz

Enrollment

1,500 participants

Start Date

Dec 1, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this Clinical Research Collaboration is to investigate the prognostic implications of pulmonary hemodynamics during exercise based on a large scale multi-centre approach by using retrospective and prospective analysis of hemodynamic data.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Patients (females and males; age: above 18yrs) with intermediate or high echocardiographic probability of PH and/or unexplained dyspnea, and/or associated conditions for PAH as clinical indication for RHC at rest and exercise
  • Written informed consent of participating subjects after being fully briefed (for prospective analysis)

Exclusion Criteria7

  • Patients with incomplete hemodynamic data at rest or exercise
  • Patients without sufficient follow-up data (information on survival / lung transplantation)
  • advanced tumour disease or other diseases with a short life expectancy, except pulmonary vascular diseases
  • advanced heart failure with pulmonary arterial wedge pressure (PAWP) > 18 mmHg at rest
  • uncontrolled systemic arterial hypertension (RR values > 160/100 mmHg at rest)
  • FEV1<50% predicted
  • TLC<60% predicted

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTassessment of pulmonary hemodynamics during exercise by right heart catheterization

all patients undergo right heart catheterization during exercise due to clinical reasons. Results of this and other Routine clinical tests will be included in the registry


Locations(32)

University of Arizona, Banner University Medical Center

Phoenix, Arizona, United States

University of California, Los Angeles, Lung & Heart-Lung Transplant and Pulmonary Hypertension Programs, David Geffen School of Medicine

Los Angeles, California, United States

Johns Hopkins Hospital, Advanced HF, MCS, Transplant Cardiology, Baltimore, Maryland, USA

Baltimore, Maryland, United States

Massachusetts General Hospital, Cardiology Division and Pulmonary Unit

Boston, Massachusetts, United States

Harvard Medical School, Brigham and Women's Hospital

Boston, Massachusetts, United States

University of Minnesota Medical School, Division of Cardiology, Department of Medicine, Lillehei Heart Institute Minneapolis, Minnesota, USA

Minneapolis, Minnesota, United States

Mayo Clinic, Division of Cardiovascular Diseases, Department of Medicine

Rochester, Minnesota, United States

Medical University of South Carolina

Charleston, South Carolina, United States

Royal Prince Alfred Hospital, Respiratory Medicine

Camperdown, Australia

Medical University of Graz

Graz, Austria

Free University of Brussels, Faculty of Medicine, Physiology

Brussels, Belgium

University of São Paulo Medical School

São Paulo, Brazil

Department of Cardiology, Aarhus University Hospital, Denmark

Aarhus, Denmark

Université de Lorraine

Nancy, France

Centre Chirurgical Marie Lannelongue, Thoracic and Vascular Surgery

Paris, France

Centre de Référence de l'Hypertension Pulmonaire, Université ParisSud - Université Paris-Saclay, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris

Paris, France

Sorbonne Universités, Neurophysiologie respiratoire expérimentale et clinique

Paris, France

University of Cologne, Klinik III fuer Innere Medizin

Cologne, Germany

Justus-Liebig-University Giessen, Department of Internal Medicine

Giessen, Germany

University of Greifswald

Greifswald, Germany

Thorax Clinic Heidelberg, Centre for Pulmonary Hypertension

Heidelberg, Germany

Academic Teaching Hospital of the Julius Maximilian University of Würzburg

Würzburg, Germany

University of Bologna

Bologna, Italy

University of Rome La Sapienza, Cardiovascular and Respiratory Sciences

Roma, Italy

VU Medisch Centrum, Pulmonology

Amsterdam, Netherlands

Otwock Medical Center of Postgraduate Education, Department of Pulmonary Circulation and Thromboembolic Diseases

Otwock, Poland

Barcelona Hospital Clínic, Pneumologia

Barcelona, Spain

University Hospital of Zurich, Internal Medicine

Zurich, Switzerland

Scottish Pulmonary Vascular Unit

Glasgow, United Kingdom

Imperial College, NHS Healthcare NHS Trust, National Pulmonary Hypertension Service

London, United Kingdom

Royal Brompton Hospital

London, United Kingdom

Royal Hallamshire Hospital, Sheffield Pulmonary Vascular Disease Unit

Sheffield, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03954574